TMO Thermo Fisher Scientific
- Official Name: THERMO FISHER SCIENTIFIC INCORPORATED
- Headquarters: 168 Third Avenue, WALTHAM, MA, 02451 US
- CEO: Marc N. Casper
- Website: thermofisher.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Won by 3.377 | (1.692) - (5.069) | ||
| 2025-07-22 | 2 | Won by 4.182 | 1.822 - (2.360) | ||
| 2025-07-29 | 3 | Won by 16.900 TOTW | 14.057 - (2.843) | ||
| 2025-07-29 | 2R | Won by 0.134 | (0.558) - (0.692) | ||
| 2025-08-05 | 4 | Lost by 2.306 | (2.664) - (0.358) | ||
| 2025-08-06 | 1R | Lost by 2.339 | (3.413) - (1.074) | ||
| 2025-08-07 | 1R | Won by 1.697 | 0.979 - (0.718) | ||
| 2025-08-12 | 5 | Won by 0.717 | 2.846 - 2.129 | ||
| 2025-08-12 | 3R | Won by 3.082 | 2.783 - (0.299) | ||
| 2025-08-19 | 6 | Won by 4.297 | 4.229 - (0.068) | ||
| 2025-08-21 | 2R | Lost by 1.316 | (1.856) - (0.540) | ||
| 2025-08-26 | 7 | Lost by 4.213 | (2.065) - 2.148 | ||
| 2025-08-26 | 4R | Lost by 0.108 | (0.463) - (0.355) | ||
| 2025-09-02 | 8 | Lost by 1.598 | (0.241) - 1.357 | ||
| 2025-09-09 | 9 | Lost by 1.154 | (1.211) - (0.057) | ||
| 2025-09-16 | 10 | Lost by 2.523 | (0.347) - 2.176 | ||
| 2025-09-23 | 11 | Lost by 6.907 | (2.196) - 4.711 | ||
| 2025-09-30 | 12 | Won by 0.512 | 2.884 - 2.372 | ||
| 2025-10-07 | 13 | Won by 4.322 TOTW | 7.909 - 3.587 | ||
| 2025-10-14 | 14 | Lost by 4.003 | (2.419) - 1.584 | ||
| 2025-10-21 | 15 | Won by 7.540 TOTW | 5.934 - (1.606) |
Latest News

Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
WALTHAM, Mass., September 01, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, cha...

Plant Virome Diagnostics Outlook 2026-2030 Featuring Profiles of Illumina, Thermo Fisher Scientific and Qiagen
Opportunities center on NGS, metagenomic profiling, portable field tests and cloud analytics, driven by viral outbreaks, precision agriculture, biosec...

Partners Group Private Equity Ltd (LSE:PEY) (Q2 2026) Earnings Call Highlights: Strong ...
Despite a challenging market, the company realized over 14% of NAV in distributions and advanced AI initiatives, while navigating a dip in portfolio p...

Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis
Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. ...

Cocrystal Pharma: The Strategic Reset Investors May Be Missing
By Mike Sheikh Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of ...

Is Thermo Fisher Scientific Stock Outperforming the Nasdaq?
Thermo Fisher Scientific has outperformed the Nasdaq over the past year, yet Wall Street analysts remain bullish on the stock, reflecting confidence t...

Trends & Strategies in the $2.9 Billion Biological Computing Market, 2026-2035 - Featuring Profiles of Microsoft, IBM, and Thermo Fisher Scientific
Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Biological Computing Market Report 2026" has been added to ResearchAndMarkets.com's offe...

Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue?
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

How Investors May Respond To Natera (NTRA) New MRD Trial Deal And Duquesne Stake Expansion
Natera recently announced a collaboration with Kupando Therapeutics to supply its Latitude tissue-free MRD assay for a Phase 1 immunotherapy trial in ...